Почетна › Мажорна депресивна поремећеност › Ilinois
Kliničke studije za Мажорна депресивна поремећеност u državi Ilinois
18 studija za Мажорна депресивна поремећеност traži učesnike na lokacijama u državi Ilinois.
Gradovi u državi Ilinois
Zvanični tekst studije (na engleskom)
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Rush University, Chicago
Тражи се учесникФаза 3
Узраст од 18 до 85 · Оба пола · Ажурирано 13. 11. 2026. · NCT06793397A Phase 3 Trial of DT120 for Major Depressive Disorder (Ascend)
- Uptown Research Institute, Chicago
Тражи се учесникФаза 3
Узраст од 18 до 74 · Оба пола · Ажурирано 9. 11. 2026. · NCT07592689Phase 3 Study of Adjunctive Treatment With Seltorexant in Adult and Elderly Participants With Major Depressive Disorder and Insomnia Symptoms
- Northwestern University, Chicago
- Baber Research Group, Naperville
Тражи се учесникФаза 3
Узраст од 18 до 74 · Оба пола · Ажурирано 3. 11. 2026. · NCT06559306A Study to Evaluate the Efficacy and Safety of Esketamine for Reduction of Symptoms of Major Depressive Disorder
- Endeavor Health Evanston Hospital, Evanston
Тражи се учесникФаза 3
Узраст од 12 до 17 · Оба пола · Ажурирано 3. 11. 2026. · NCT07227454A Study of Brenipatide (LY3537031) in Adult Participants With Major Depressive Disorder
- Charter Research - Chicago, Chicago
Тражи се учесникФаза 3
Узраст од 18 до 75 · Оба пола · Ажурирано 3. 11. 2026. · NCT07775300A Study of Seltorexant as Monotherapy in Adults and Elderly Participants With Major Depressive Disorder
- Chicago Research Center, Chicago
Тражи се учесникФаза 3
Узраст од 18 до 74 · Оба пола · Ажурирано 3. 11. 2026. · NCT07573176A Study to Evaluate TNX-102 SL Monotherapy Versus Placebo in Participants With Major Depressive Disorder (MDD)
- Clinical Research Site, Chicago
Тражи се учесникФаза 2
Узраст 18 и старији · Оба пола · Ажурирано 30. 10. 2026. · NCT07621237Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- AMR Conventions Research, Warrenville
Тражи се учесникФаза 2
Узраст од 18 до 70 · Оба пола · Ажурирано 28. 10. 2026. · NCT07226661Treatment ResistAnt Depression Subcallosal CingulatE Network DBS (TRANSCEND)
- Rush University Medical Center, Chicago
- University of Chicago, Chicago
Тражи се учесник
Узраст од 22 до 70 · Оба пола · Ажурирано 16. 10. 2026. · NCT06423430A Study to Evaluate the Effectiveness of DT-101 as an Adjunctive Treatment in Patients With Depression
- Draig Clinical Site, Chicago
- Draig Clinical Site, Skokie
Тражи се учесникФаза 2
Узраст од 18 до 75 · Оба пола · Ажурирано 14. 10. 2026. · NCT07610473Clinical Assessment of Response in the Treatment of Depression With Daytime Sleepiness Using Solriamfetol
- Clinical Research Site, Chicago
Тражи се учесникФаза 3
Узраст од 18 до 65 · Оба пола · Ажурирано 13. 10. 2026. · NCT07484217Evaluation of Efficacy and Safety of Milsaperidone as Adjunctive Therapy in Patients With Major Depressive Disorder
- Vanda Investigational Site, Chicago
Тражи се учесникФаза 3
Узраст од 18 до 65 · Оба пола · Ажурирано 24. 9. 2026. · NCT06830044A Study to Evaluate the Effectiveness of Valbenazine in Adult Participants With Tardive Dyskinesia (TD) Who Remain Symptomatic While Receiving or After Stopping a Vesicular Monoamine Transporter 2 (VMAT2) Inhibitor
- Neurocrine Clinical Site, Naperville
Тражи се учесникФаза 4
Узраст 18 и старији · Оба пола · Ажурирано 18. 9. 2026. · NCT07105111A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder
- EmVenio Research, Chicago
Тражи се учесникФаза 2
Узраст од 18 до 64 · Оба пола · Ажурирано 27. 7. 2026. · NCT07115329A Study to Assess Change in Disease Activity and Adverse Events of Oral Icalcaprant in Adult Participants With Major Depressive Disorder
- Flourish Research - Great Lakes Clinical Trials /ID# 278201, Chicago
- Amr Conventions Research /ID# 277547, Warrenville
Тражи се учесникФаза 2
Узраст од 18 до 65 · Оба пола · Ажурирано 15. 6. 2026. · NCT07276997Exercise Training for Managing Major Depressive Disorder in Multiple Sclerosis
- University of Illinois at Chicago, Chicago
Тражи се учесник
Узраст од 18 до 64 · Оба пола · Ажурирано 4. 6. 2026. · NCT05051618Biomarkers/Biotypes, Course of Early Psychosis and Specialty Services
- University of Chicago Medical Center, Chicago
Тражи се учесникОпсервациона студија
Узраст од 18 до 40 · Оба пола · Ажурирано 10. 3. 2026. · NCT06740383A Study to Evaluate the Efficacy of AXS-05 Compared to Bupropion in Preventing the Relapse of Depressive Symptoms
- Clinical Research Site, Chicago
Тражи се учесникФаза 4
Узраст од 18 до 65 · Оба пола · Ажурирано 23. 1. 2025. · NCT06223880Sa sajta ClinicalTrials.gov, podaci preuzeti 15. 11. 2026.. Svaka studija ima svoje kriterijume za uključivanje; tim studije odlučuje ko može da učestvuje.